Per-ola Freskgard
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
MEDI1814 selectively reduces free Aβ42 in cerebrospinal fluid of non-clinical species and Alzheimer's disease patients.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 03, 2024
Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans.
Journal: mAbs
Published: October 12, 2023
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct.
Journal: Nature communications
Published: April 01, 2022
Brain Shuttle Neprilysin reduces central Amyloid-β levels.
Journal: PloS one
Published: January 02, 2020
First Infusion Reactions are Mediated by FcγRIIIb and Neutrophils.
Journal: Pharmaceutical research
Published: March 29, 2018
Region-specific permeability of the blood-brain barrier upon pericyte loss.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: March 10, 2017
Trafficking of Endogenous Immunoglobulins by Endothelial Cells at the Blood-Brain Barrier.
Journal: Scientific reports
Published: October 09, 2015
Cargo Delivery into the Brain by in vivo identified Transport Peptides.
Journal: Scientific reports
Published: April 08, 2015
Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells.
Journal: Nature cell biology
Published: September 16, 2014
Last Updated: 09/26/2026